EF
ABBV icon

Empowered Funds’s AbbVie ABBV Stock Holding History

Empowered Funds’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9M Sell
202,359
-24,477
-11% -$5.27M 0.27% 66
2026
Q1 		$49.3M Buy
226,836
+78,374
+53% +$17.4M 0.31% 53
2025
Q4 		$33.9M Buy
148,462
+12,395
+9% +$2.82M 0.58% 29
2025
Q3 		$31.5M Buy
136,067
+17,375
+15% +$3.54M 0.32% 46
2025
Q2 		$22M Buy
118,692
+9,066
+8% +$1.68M 0.25% 75
2025
Q1 		$23M Buy
109,626
+12,448
+13% +$2.42M 0.33% 44
2024
Q4 		$17.3M Buy
97,178
+15,934
+20% +$2.93M 0.25% 65
2024
Q3 		$16M Sell
81,244
-9,361
-10% -$1.75M 0.25% 72
2024
Q2 		$15.5M Buy
90,605
+45,606
+101% +$7.55M 0.27% 58
2024
Q1 		$8.19M Sell
44,999
-32,584
-42% -$5.62M 0.15% 168
2023
Q4 		$12M Buy
77,583
+8,438
+12% +$1.23M 0.3% 45
2023
Q3 		$10.3M Buy
69,145
+46,348
+203% +$6.8M 0.3% 46
2023
Q2 		$3.07M Buy
22,797
+72
+0.3% +$10.6K 0.11% 263
2023
Q1 		$3.62M Buy
+22,725
New +$3.47M 0.21% 136
2022
Q4 		– Sell
-8,436
Closed -$1.29M – 440
2022
Q3 		$1.13M Sell
8,436
-10,214
-55% -$1.47M 0.11% 155
2022
Q2 		$2.86M Buy
18,650
+12,630
+210% +$1.93M 0.37% 89
2022
Q1 		$976K Buy
6,020
+212
+4% +$30.8K 0.11% 188
2021
Q4 		$786K Buy
5,808
+763
+15% +$90.1K 0.09% 174
2021
Q3 		$544K Buy
5,045
+2,209
+78% +$252K 0.07% 168
2021
Q2 		$319K Buy
+2,836
New +$319K 0.04% 206
2019
Q4 		– Sell
-32,296
Closed -$2.44M – 103
2019
Q3 		$2.44M Buy
+32,296
New +$2.21M 1.06% 11
2018
Q2 		– Sell
-10,276
Closed -$969K – 93
2018
Q1 		$969K Buy
10,276
+375
+4% +$41.2K 0.35% 91
2017
Q4 		$958K Buy
+9,901
New +$933K 0.48% 62

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Empowered Funds's ABBV Position: Q2 2026 in Review

Empowered Funds reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $5.27M and leaving 202,359 shares worth $50.9M. The position accounts for 0.27% of the portfolio, ranked #66.

Empowered Funds first reported a position in ABBV in Q4 2017 and has held it in 23 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Empowered Funds held 202,359 shares of AbbVie worth $50.9M as of Q2 2026.
  • Empowered Funds sold 24,477 AbbVie shares in Q2 2026, an estimated $5.27M.
  • AbbVie made up 0.27% of Empowered Funds's portfolio in Q2 2026, its #66 holding.
  • Empowered Funds first reported a position in AbbVie in Q4 2017 and has held it in 23 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.